People: Agenus Inc (AGEN.PH)

AGEN.PH on Philadelphia Stock Exchange

7.97USD
3:51pm EDT
Change (% chg)

$-0.10 (-1.24%)
Prev Close
$8.07
Open
$7.99
Day's High
$8.18
Day's Low
$7.73
Volume
8,335
Avg. Vol
12,983
52-wk High
$8.27
52-wk Low
$2.62

Search Stocks

Malik, Shahzad 

Dr. Shahzad Malik, M.D., is Independent Director of Agenus Inc. Dr. Malik is a General Partner at Advent Venture Partners, a position he has held since 1999. Dr. Malik brings to our Board historical knowledge of the operations of 4-Antibody AG, our wholly-owned subsidiary (“4-Antibody”), as well as broad experiences in the life sciences and medical industries. During his time with Advent, he has been actively involved with numerous investments in Europe and the United States in the biopharmaceutical and medical device arenas in a variety of therapeutic areas. A number of these companies that Advent invested in are now publicly traded or have been acquired. Dr. Malik currently serves on the Board of Directors of Conatus Pharmaceuticals, Inc. and Versartis, Inc., both life sciences companies. Prior to joining Advent, Dr. Malik spent six years practicing medicine before joining the London office of McKinsey & Company, a management consulting firm. While there he served international clients in the Healthcare and Investment Banking sectors.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Garo Armen

2,283,530

Robert Stein

1,572,510

Christine Klaskin

601,228

Karen Valentine

864,071

Ozer Baysal

593,602

Timothy Wright

--
As Of  30 Dec 2014
Search Stocks